March 12, 2021
The Ministry of Health, Labor and Welfare (MHLW) on March 11 granted orphan drug designation to eight APIs including Eli Lilly’s baricitinib, which carries the trade name of Olumiant, for the indication of type I interferon-mediated autoinflammatory diseases. The seven...read more